Arteriovenous Fistula Global Clinical Trials Review, H2, 2016

GlobalData
49 Pages - GLDATA57639
$2,500.00

Summary

GlobalData's clinical trial report, “Arteriovenous Fistula Global Clinical Trials Review, H2, 2016" provides an overview of Arteriovenous Fistula clinical trials scenario. This report provides top line data relating to the clinical trials on Arteriovenous Fistula. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies Mentioned

Proteon Therapeutics Inc
C. R. Bard Inc
Shire Plc
Enceladus Pharmaceuticals BV
Eiger BioPharmaceuticals Inc
Cyathus Exquirere Pharmaforschungs GmbH
Changi General Hospital Pte Ltd
Boston Scientific Corp
Bard Peripheral Vascular OEM Products
AstraZeneca Plc

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Clinical Trials by G7 Countries: Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Arteriovenous Fistula Therapeutics Clinical Trials 23
Prominent Drugs 25
Clinical Trial Profile Snapshots 26
Appendix 46
Abbreviations 46
Definitions 46
Research Methodology 47
Secondary Research 47
About GlobalData 48
Contact Us 48
Disclaimer 48
Source 49

List of Tables
Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Region, 2016* 5
Arteriovenous Fistula Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Arteriovenous Fistula Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 8
Arteriovenous Fistula Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9
Arteriovenous Fistula Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
Arteriovenous Fistula Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11
Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 12
Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 15
Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Phase, 2016* 16
Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 17
Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Trial Status, 2016* 18
Arteriovenous Fistula Therapeutics Clinical Trials, Global, by End Point Status, 2016* 19
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 20
Arteriovenous Fistula Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 21
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 22
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25

List of Figures
Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Arteriovenous Fistula Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Arteriovenous Fistula Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 8
Arteriovenous Fistula Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9
Arteriovenous Fistula Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10
Arteriovenous Fistula Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 11
Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 12
Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 15
Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Phase (%), 2016* 16
Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 17
Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Trial Status, 2016* 18
Arteriovenous Fistula Therapeutics Clinical Trials, Global, by End Point Status, 2016* 19
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 20
Arteriovenous Fistula Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 21
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 22
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 23
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25
GlobalData Methodology 47

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports